Tirzepatide was developed by Eli Lilly and received FDA approval in May 2022 under the name Mounjaro as a Type 2 diabetes treatment
Discuss appropriate monitoring with your clinician if using for longevity-focused goals
GLP-1 weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are changing more than waistlinesthey're reshaping the wellness and beauty industry
(2023) found that GLP-1 receptor agonists reduced the risk of lower limb amputation by 43% compared to sulfonylureas (HR: 0.57, 95% CI: 0.390.84), with the greatest risk reduction observed in long-term users (HR: 0.44, 95% CI: 0.270.72).(26) However, GLP-1 receptor agonists did not significantly impact diabetic foot ulcer incidence (HR: 1.08, 95% CI: 0.871.35)
Furthermore, there was a propensity score matching to reduce bias
The advertising industry has been pushing images of skinny women all my life, and our society prefers skinny people, especially skinny women